Stay updated with breaking news from Gregory Oakes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Landos' lead asset, NX-13, is a first-in-class, oral NLRX1 agonist in Phase 2 for the treatment of ulcerative colitis NORTH CHICAGO, Ill. and NEW YORK, March 25, 2024 /PRNewswire/ -- AbbVie Inc. ...
By Sabela Ojea AbbVie is acquiring Landos Biopharma for about $137.5 million to advance the development of the oral molecule NX-13, aimed at treating ulcerative colitis and Crohn's disease. ...
Gregory Oakes will step down after his third 4-year term as the county's top prosecutor.
The state's life sciences trade association, BioNJ, recently announced the election of its 2023 officers and board members.
A Blackburg-born biotech company striving to bring a medicine to market began the year with sobering news: With cash an issue, it would bear down on developing a single drug